← Back to Analyst Consensus 
MIRA Buy
MIRA PHARMACEUTICALS, INC.
Current Price —
Implied Upside —
Analysts 7
30-Day Momentum
▲ 0 upgrades / ▼ 0 downgrades / 0 reiterations from 0 firms
Next Earnings
Nov 11, 2026 (16 days)
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Sep 17, 2026 | Maxim Group | initiate | — → Buy | — | 42% |
| Sep 30, 2024 | Rodman & Renshaw | initiate | — → Buy | $17 | 40% |
| Aug 5, 2024 | Ascendiant Capital | initiate | — → Buy | $11 | 38% |
Price Target Trend
Sep 18, 2026 Latest: $3.5 Oct 25, 2026
EPS Estimates
+1q $-0.03
Lo: $-0.03 Hi: $-0.03
1 analysts +1y $-0.16
Lo: $-0.16 Hi: $-0.16
1 analysts 0q $-0.03
Lo: $-0.03 Hi: $-0.03
1 analysts 0y $-0.12
Lo: $-0.12 Hi: $-0.12
1 analysts ▲1
Cross-Platform Signals
No cross-platform signals in the last 90 days